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Abstract
Objective: To estimate and rank the relative severity of self-reported diseases and symptoms in
Denmark.
Method: The 1994 Danish Health and Morbidity Survey collected data from 5,472 Danes older
than 16 years of age. Interviews (response frequency: 79%) gave information on diseases and
symptoms; a self-administered SF-36 questionnaire (response frequency: 64%) provided
information on health-related quality of life. The severity of diseases and symptoms was
represented by the health-related quality of life scores that individuals suffering from particular
diseases and symptoms obtained on the single dimensions of the SF-36 and on a combined sum of
all dimensions. We applied logistic regression to control for the influence of sex, age and socio-
economic status on the SF-36 score. We also analysed the interaction between socio-economic
status and diseases on the SF-36 score.
Results: Females, more frequently than males, reported on all symptoms and all disease groups
except injuries. People with relatively low levels of education reported most diseases, especially
musculoskeletal and cardiovascular diseases, more frequently than people with higher education.
Age-adjusted mean SF-36 scores for all dimensions combined showed that the symptoms of
melancholy/depression and breathing difficulties, psychiatric disorders and respiratory diseases
scored lowest (i.e. were most often associated with worse health). Females had lower SF-36
combined scores (worse health) than males on all symptoms. We found interaction between socio-
economic status and respiratory diseases and musculoskeletal diseases on the SF-36 score. SF-36
scores also indicated significantly worse health among Danes with low education and income levels
compared to those with higher education and income.
Conclusion: In 1994 the Danes most frequently reported musculoskeletal symptoms and diseases.
Psychiatric disorders and respiratory diseases were identified as the most severe reported
diseases. Due to the interaction between socio-economic status and some diseases, severity
estimates should be interpreted with caution or stratified by socio-economic groups.
Introduction
For the purposes of prioritizing and planning of health
care resources, it is important to obtain information on
the degree to which each single disease constitutes a bur-
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den. The societal burden of a disease is a combination of
its prevalence, duration and severity. The purpose of this
study is to estimate and rank severities for the most prev-
alent self-reported diseases and symptoms in Denmark
based on individual self-administrated SF-36 health-
related quality of life profiles.
Based on a review of more than a thousand studies world-
wide using the SF-36 questionnaire, Ware [1] concluded
that the SF-36 is useful for descriptive purposes such as
documenting differences between diseased patients and
ones with good health levels, and for estimating the rela-
tive burden of different medical conditions. In this study
we will estimate the relative severity of diseases and symp-
toms based on the scores that individuals suffering from
these self-reported diseases and symptoms obtained on
the single dimensions of the SF-36 and on all dimensions
combined. We will examine how the SF-36 scores vary by
age, sex, socio-economic status (SES), and will rank symp-
toms and disease groups according to their relative sever-
ity.
Data and methods
The data used in this study are from the 1994 Danish
Health and Morbidity Survey of the National Institute of
Public Health in Denmark [2]. The total sample of 6,787
adults older than 16 years of age comprised a representa-
tive national sample of 4,668 people, plus data on 2,119
people from two Danish counties collected in the same
year. The sampling was based on only two criteria: being
a Danish citizen aged 16 years or more and being non-
institutionalized. Data were collected through a 45-
minute interview and a self-administered questionnaire to
be mailed back within two weeks. The inclusion of the
additional 2,119 people increased the statistical power to
the estimated SF-36 weights. The two counties' samples
have the same age and sex pattern as the rest of the sur-
veyed population and do not have any special health char-
acteristics different from the rest of the country.
The specific SF-36 questionnaire was part of the self-
administered questionnaire. SF-36 contains 36 items
which cover eight dimensions of health-related quality of
life: bodily pain (BP), general health (GH), mental health
(MH), physical functioning (PF), role emotional limita-
tions due to health (RE), role physical limitations due to
health (RP), social functioning (SF), and vitality (VI).
Each of the scales gives a score between 0 (worst) and 100
(best). It is possible to calculate the SF-36 scale value for
an individual response if at least half of the items in each
SF-36 scale are answered. An analysis by Bjørner and col-
leagues [3] of the same national survey found that the per-
centage of the Danish population for whom it is possible
to calculate the SF-36 dimension scores varies from 93%
(general health scale) to 100% (social function scale). The
only dimension for which calculating a score was a prob-
lem was general health among respondents older than 66
years of age, where it was possible to calculate the scale
value for only 79% of the incoming responses. Other
studies on the same national sample [4,6] have more
details on tests of data quality, scaling assumptions, relia-
bility and validation of the translation of the Danish SF-
36.
The 1994 survey also contains a broad range of informa-
tion about health status, diseases, symptoms, and back-
ground information such as age, sex, residence, education,
profession, and ethnicity.
Education was defined as a combination of school and
vocational training based on the International Standard
Classification of Education (ISCED). According to their
level of education respondents were placed in three
groups: individuals in the low level of education group
had less than 10 years of education; those in the middle
group had 10–12 years of education; and in the high one
individuals had more than 13 years of education.
Income was defined as personal income before tax (DKK/
year): low income ranges from 0–99,000; middle income
– from 100,000–199,000, and high income – from
200,000 and above.
Information on long-standing diseases originated from an
open-ended question "Do you suffer from any long-
standing illness, long-standing after-effect from injury,
any disability or other long-standing (6+ months) condi-
tion?" An affirmative answer led to questions about the
specific nature of the illness, including where in the body
the illness was located, about how long it had been there,
whether a medical doctor had diagnosed it, and whether
the illness gave much or little limitation in work and daily
life. Answers to questions were coded into 14 main groups
according to a modified version of the World Health
Organization's International Classification of Diseases (ICD-
8): infectious/parasitic diseases, malignant neoplasm, dis-
eases of the endocrine system, blood diseases, psychiatric
disorders, diseases of the nervous system, cardiovascular
diseases, respiratory diseases, digestive diseases, genito-
urinary diseases, skin diseases, musculoskeletal diseases,
injuries, and other diseases. SF-36 scores were not calcu-
lated for disease prevalence lower than 1%.
The survey listed 14 different symptoms and asked the
participants if they had experienced these in the two
weeks prior to the survey point. The symptoms were:
shoulder/neck pain, back pain, arm/leg pain, headache,
palpitations, worrying, sleeping problems, melancholy/
depression, fatigue, stomach ache, constipation, eczema,
cold/rhinitis/coughing, and breathing difficulties.Population Health Metrics 2006, 4:3 http://www.pophealthmetrics.com/content/4/1/3
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In the interest of knowing the upper end-point of average
SF-36 dimension scores, we defined a subsample of per-
sons who reported having no diseases currently or previ-
ously, no long-standing diseases, and no symptoms, pain
or complaints.
The statistical methods involved first, applying the origi-
nal SF-36 scale score algorithm, which from polytomous
response categories ranging from 2 to 6 response choices
per item, yields a 8-dimensional profile, with each scale
having a range from 0 to 100 (100 = optimal) [3,7]. Sec-
ond, we tabulated the distribution of the eight specific SF-
36 dimension scores for respondents reporting different
diseases and symptoms, according to sex, income and
education, and adjusted for age differences.
The estimation of the relative severity of diseases and
symptoms was based on the scores that individuals suffer-
ing from the self-reported diseases and symptoms
obtained on both the eight single dimensions and on a
combined total score, calculated as a simple average of all
eight sub-scales.
We used logistic regression analysis to control for the
influence of sex, age and SES on the SF-36 combined score
after having tested for interaction between these factors
and diseases on the SF-36 score. We entered all variables
as dummies. The SF-36 combined scale score was dichot-
omised to over and under 80. The cut-off point at 80 was
arbitrarily set on the basis of the distribution of the SF-36
combined scale score for the entire sample (mean
females: 80.1, males: 84.7, all: 82.1). From the combined
score we ranked the age-adjusted relative severity of dis-
eases separated by sex and educational groups (using the
International Standard Classification of Education
(ISCED) where low is less than 10 years of education and
high is more than 10 years of education).
Results
The overall response rate to the interviews in the 1994
Danish Health and Morbidity Survey was 79% and to the
self-administered SF-36 questionnaire, 64% (N = 5,472).
Characteristics of the study population appear in the first
column of Table 1. The study includes nearly equal num-
bers of males (48%) and females (52%). More males and
Table 1: SF-36 Dimensions and Combined Scores on 8 Dimensions in Age-adjusted Socio-demographic Subgroups and in a Subgroup 
without Illness (100 = Optimal).
N BP GH MH PF RE RP SF VI Comb
Age 16–24 years 881 83.4 83.2 81.6 96.7 91.7 93.6 95.0 72.9 87.3
25–44 years 2180 81.5 80.4 82.1 94.6 88.9 90.5 92.8 70.6 85.2
45–64 years 1691 77.8 73.0 82.1 85.7 87.0 80.8 90.9 70.2 80.9
65+ years 720 75.8 64.6 80.5 70.6 73.1 59.4 87 65.5 72.1
Sex Males 2828 83.4 77.5 83.9 90.9 89.0 86.5 93.3 72.9 84.7
Females 2644 76.4 75.4 80.0 86.7 83.6 80.7 90.3 67.6 80.1
Education Males
Low 613 78.6 70.6 82.3 82.3 82.3 75.7 89.6 69.8 78.9
Mid 746 82.1 77.0 84.3 89.8 89.4 85.3 93.7 73.0 84.3
High 1313 86.2 80.2 84.1 94.8 91.0 91.5 94.3 73.9 87.0
Females
Low 435 69.4 64.4 77.4 71.8 75.4 64.6 85.9 63.0 71.5
Mid 864 76.6 75.0 79.8 86.8 85.2 81.0 90.0 67.5 80.2
High 1234 80.1 79.6 81.4 92.4 88.2 86.7 92.3 69.5 83.8
Income Males
Low 529 80.8 74.4 81.6 86.2 84.5 79.4 91.0 69.6 80.9
Mid 759 81.2 75.6 83.2 88.5 86.3 82.8 92.2 72.3 82.7
High 1294 85.9 80.0 85.2 94.5 92.8 92.2 94.8 74.6 87.5
Females
Low 899 72.4 68.3 77.4 78.1 79.2 71.2 87.4 63.9 74.7
Mid 1262 77.8 77.1 80.7 89.7 86.7 84.1 91.5 68.6 82.0
High 524 81.0 81.8 82.9 93.4 90.3 88.8 93.1 71.1 85.3
No illness Males 548 95.8 86.7 89.5 95.8 95.7 95.1 97.6 82.3 92.3
Females 286 94.9 87.0 88.4 95.3 95.4 96.2 97.6 79.6 91.8
Entire sample 5472 79.7 76.0 81.8 88.2 86.6 82.9 91.6 70.0 82.1Population Health Metrics 2006, 4:3 http://www.pophealthmetrics.com/content/4/1/3
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females from the study population are in the higher edu-
cational group. More males from the survey are in the
highest income group, whereas more females are in the
mid income group.
The nonrespondents have been characterized with respect
to gender, age, region, county, and marital status. The
odds for nonresponse in the survey increased by age and
the increase was gender-specific. For individuals between
15 and 59 years of age, the odds for participation were
lower for men than for women. Among people older than
59 years, the odds for non-participation were higher for
widowed, divorced, and unmarried people than for mar-
ried people. Finally, the odds for non-participation
increased with urbanization [2,8].
Table 1 shows SF-36 dimension scores and the combined
score across the different basic population characteristics
of the sample. The age-adjusted SF-36 combined score
across the eight dimensions for the entire sample is 82.1,
with females and elderly people having lower scores
(worse health) than males and younger age groups on all
dimensions. The scores on the physical functioning (PF)
and role physical (RP) dimensions are lower for the repre-
sentatives of the 45–64 age group, and together with the
scores on the general health (GH) and role emotional
(RE) dimensions, they are the lowest for individuals older
than 65 years. The respondents with the highest com-
bined scores in the sample, i.e. the healthiest people, are
those with no diseases currently or previously, no long-
standing diseases, no symptoms, pain or complaints
reported. Both males and females reported the highest
combined score (97.6) for social functioning (SF). The
lowest score in the healthiest group, 79.6, is for females
on the vitality index (VI).
Table 2 shows confidence intervals (95%) for various rep-
resentative sample sizes for each SF-36 dimension score.
This table can serve as a tool for the reader when compar-
ing various dimension scores, and is therefore presented
here instead of large tables with uncertainties around all
estimates.
Individuals with lower SES have lower SF-36 scores on all
dimensions compared to others. This is seen both with
regard to education (Figure 1) and income (Figure 2).
Table 3 shows the total prevalence by sex of 14 different
symptoms reported as apparent in the two weeks prior to
the survey. Females reported more symptoms than males
did for all symptoms in the list. The most commonly
reported symptoms for both sexes are pain or discomfort
in shoulder and/or neck and back pain. The largest gender
difference in symptom prevalence is observed for head-
ache, worrying, depression and general unhappiness, and
sleeping problems. All in all, women reported more
symptoms than men did, and they also had lower SF-36
scores for all 14 symptoms.
For both sexes, the two most severe reported symptoms
according to age-adjusted SF-36 combined score are mel-
ancholy/depression (males: 65.0, females: 62.3) and
breathing difficulties (males: 66.5, females: 64.4). For the
commonly reported symptoms back pain and shoulder/
neck pain, the average rankings are at numbers 11 and 13
respectively for males and at 9 and 12 for females.
Younger people reported primarily the mildest symp-
toms: headache, shoulder/neck pain, colds/rhinitis/
coughing, and fatigue (not in Table). Elderly people
reported greater health problems such as breathing diffi-
culties, palpitations, constipation, sleeping problems, and
pain in arms/legs (not in Table). The relationship between
prevalence and consequences of symptoms seems in gen-
eral to be inverse, i.e. the more prevalent the symptom,
the less severe the reported consequences.
Figure 3 shows the self-reported diseases by sex. The prev-
alence is highest for musculoskeletal diseases (males:
10.2%, females: 14.4%), cardiovascular diseases (males:
4.6%, females: 4.7%), and respiratory diseases (males:
Table 2: 95% Confidence Intervals of SF-36 Dimension Scores According to Different Sample Sizes. 1994 Danish Health and Morbidity 
Survey (N = 5472).
SF-36 dimension N = 100 N = 500 N = 1000 N = 2000 N = 5472
Lower Upper Lower Upper Lower Upper Lower Upper Lower Upper
Bodily pain 76.5 85.2 77.6 81.8 78.1 81.2 77.9 80.1 79.2 80.4
General health 71.7 80.5 73.2 77.1 74.6 77.4 75.2 77.1 76.0 77.0
Mental health 77.7 84.1 79.7 82.6 80.5 82.6 80.6 82.1 81.4 82.2
Physical functioning 90.8 95.4 87.1 90.8 87.5 90.1 87.8 89.6 88.3 89.3
R o l e  e m o t i o n a l 7 5 . 28 9 . 08 2 . 68 8 . 18 3 . 98 7 . 78 5 . 08 7 . 68 5 . 98 7 . 3
R o l e  p h y s i c a l 8 1 . 09 2 . 88 1 . 18 7 . 08 0 . 48 4 . 68 1 . 18 4 . 18 2 . 88 4 . 4
Social functioning 91.1 96.9 89.5 92.8 90.4 92.7 90.8 92.4 91.3 92.1
Vitality 64.6 72.9 66.7 70.4 68.0 70.7 68.2 70.1 69.6 70.7Population Health Metrics 2006, 4:3 http://www.pophealthmetrics.com/content/4/1/3
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4.6%, females: 4.7%). With the exception of injuries and
blood diseases, females reported more of all diseases than
males did.
Table 4 presents the results of the logistic regression anal-
ysis relating sex, age, education, and diseases to the SF-36
combined scores. Model 1 shows that sex, age, and educa-
tion are significantly related to the SF-36 combined score.
Higher educational groups have a higher SF-36 combined
score. Model 2 demonstrates a statistically significant rela-
tionship between all diseases, except skin diseases, to
lower SF-36 scores, with the largest effect for psychiatric
disorders. On the SF-36 combined score, we found no
interaction between sex and diseases, while there was
interaction between age and respiratory diseases and skin
diseases. Model 3 estimates the full model containing
both education and diseases and the interaction between
them on the SF-36 combined score. We observed interac-
tion between education and both respiratory and muscu-
loskeletal diseases in relation to the SF-36 combined
score. Only these two diseases are shown in model 3. No
interaction was established between income levels and
any of the investigated disease groups in relation to SF-36
(not in Table).
Tables 5 and 6 show the prevalence and severity of dis-
eases for males and females. Due to the interaction
between education and some diseases on the SF-36 com-
bined score, which is found in the logistic regression, the
tables are stratified by education. Males with relatively
low education reported more of nearly all diseases than
males with higher education did. 25.8% of females with
less education and 14.1% of females with higher educa-
tion claimed that they suffered from musculoskeletal dis-
eases. At the same time, 21.2% of males with less
education and 11.8% with higher education reported suf-
fering from these diseases. Cardiovascular diseases were
the second most reported disease group for both sexes,
but with a threefold difference in frequency between low
educated females and those with higher education (low:
12.6%, high: 3.6%). Respiratory diseases were the third
most reported disease group, also more frequently
reported by individuals with low education. Females
reported more of all diseases than males did, except for
injuries among respondents with higher education.
Age-adjusted SF-36 Dimension Scores (100 = Optimal)  According to Income Level Figure 2
Age-adjusted SF-36 Dimension Scores (100 = Optimal) 
According to Income Level.
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Age-adjusted SF-36 Dimension Scores (100 = Optimal)  According to Educational Level (ISCED) Figure 1
Age-adjusted SF-36 Dimension Scores (100 = Optimal) 
According to Educational Level (ISCED).
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As for the ranking of the SF-36 combined score of all
dimensions, psychiatric disorders ranked number one for
both males and females with higher education (Tables 5
and 6). Among individuals with lower education, the
most severe reported conditions were respiratory diseases
for females and psychiatric disorders for males. The over-
all combined score for psychiatric disorders was lower for
males (worse health) than for females. The score for males
with low education on the SF-36 combined score was
extremely low (50.1), and it was even lower on the general
health dimension (20.6) and the vitality index (36.6). For
all other reported diseases female scores were substan-
tially lower than male scores. The most frequently
reported disease group, musculoskeletal diseases, was
ranked with a higher relative severity by males and
females with high levels of education. Females with low
education had very low scores on the role physical (44.5)
and bodily pain (50.8) dimensions.
Discussion
We have used the original eight dimension scales in the
SF-36, as well as an average of all dimensions combined,
to rank diseases and symptoms. A recent study [9] meas-
ured the relative severity of seven chronic diseases in eight
countries (Denmark, France, Germany, Italy, Japan, the
Netherlands, Norway, and USA). By using multivariate
Prevalence of Self-reported Diseases for Males and Females Figure 3
Prevalence of Self-reported Diseases for Males and Females.
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Table 3: Prevalence of Symptoms and Ranking of Symptoms According to Age-adjusted SF-36 Dimensions and Combined Scores (100 
= Optimal) for Males and Females.
Sex Rank Symptom Prevalence % BP GH MH PF RE RP SF VI SF-36 comb
Males 1 Melancholy, depression 3.1 70.7 59.2 57.9 83.3 56.3 70.0 71.4 51.2 65.0
2 Breathing difficulties 4.1 62.8 52.2 75.5 72.3 68.6 64.8 82.1 53.5 66.5
3 Worrying 2.9 68.9 59.3 61.9 87.2 59.7 73.7 74.0 52.0 67.1
4 Palpitations 2.6 70.3 62.8 71.6 82.6 70.4 74.2 80.0 57.9 71.2
5 Sleeping problems 5.4 71.0 65.0 71.5 83.1 74.2 71.8 82.0 57.0 72.0
6 Stomach ache 3.8 68.1 66.4 75.9 86.0 78.1 72.4 84.3 61.4 74.1
7 Constipation 2.9 74.9 65.9 76.5 86.0 76.4 75.7 85.1 61.0 75.2
8 Fatigue 9.8 76.3 66.5 75.9 87.4 82.7 76.2 86.3 57.4 76.1
9 Eczema 4.1 77.5 69.2 77.6 86.6 79.0 78.3 88.3 64.7 77.7
10 Arm, leg pain 14.4 69.0 71.2 81.8 85.9 84.5 77.1 90.6 66.8 78.4
11 Back pain 18.5 69.9 71.6 80.9 87.3 85.7 79.2 90.8 66.2 78.9
12 Headache 11.1 73.5 71.9 80.1 90.1 85.5 81.3 88.9 65.4 79.6
13 Shoulder, neck pain 17.3 74.0 74.2 81.0 90.3 85.7 82.6 91.7 67.6 80.9
14 Colds, rhinitis, coughing 11.3 82.9 74.7 82.1 89.9 86.2 82.2 91.0 69.0 82.3
Females 1 Melancholy, depression 7.4 63.7 60.4 57.4 76.0 56.4 61.7 74.1 49.0 62.3
2 Breathing difficulties 4.7 62.5 55.2 72.5 68.9 64.5 57.1 80.9 53.6 64.4
3 Worrying 6.0 66.8 62.1 62.3 78.2 60.5 64.4 77.3 52.8 65.5
4 Fatigue 14.2 61.7 59.9 70.4 76.7 71.0 58.6 79.9 49.3 65.9
5 Palpitations 4.2 61.8 61.6 68.4 74.7 67.6 60.7 82.1 54.9 66.5
6 Sleeping problems 10.9 62.8 62.1 67.8 77.2 66.0 62.8 80.0 53.3 66.5
7 Stomach ache 6.8 57.8 62.4 71.2 77.6 74.6 65.7 79.9 54.9 68.0
8 Constipation 7.0 63.3 64.2 71.5 78.4 71.9 63.9 81.6 55.2 68.8
9 Back pain 25.0 61.4 65.0 75.0 78.5 75.7 65.6 84.5 57.7 70.4
10 Arm, leg pain 21.2 61.4 65.0 75.0 78.5 75.7 65.6 84.5 57.7 70.4
11 Headache 19.0 65.3 68.2 74.4 81.2 81.0 69.9 84.1 59.9 73.0
12 Shoulder, neck pain 29.3 65.9 68.6 75.9 81.0 79.6 71.6 86.2 60.6 73.7
13 Eczema 6.4 69.6 65.5 78.1 80.0 84.2 69.6 85.7 59.5 74.0
14 Colds, rhinitis, coughing 12.0 74.4 70.3 78.2 84.7 81.9 74.6 87.7 64.9 77.1Population Health Metrics 2006, 4:3 http://www.pophealthmetrics.com/content/4/1/3
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linear regression on the two standard SF-36 summary
measures for mental health (consisting of VT, SF, RE, MH
dimension scales) and physical health (PF, RP, BP, GH
dimension scales), it was found that hypertension, aller-
gies, and arthritis were the most frequently reported con-
ditions, while arthritis, chronic lung disease, and
congestive heart failure were the most severe ones. Also
Sprangers and colleagues [10] used the standard SF-36
summary measures for mental and physical health to esti-
mate the relative severity of chronic diseases. They estab-
lished that patients who were older, female, with low
education, who lived alone and had at least one co-mor-
bid condition, in general reported the poorest level of
quality of life as measured by the SF-36. Differences in
background variables and disease groups make compara-
bility across populations difficult, even with a standard-
ized questionnaire like the SF-36. In addition, there is a
likely difference in reporting behaviour and health norms
across populations and groups. However, the results seem
in general to be in concordance with our findings.
Considerable evidence suggests response shifts from self-
reported health data both across countries and within
countries across age, sex, and socio-economic groups [11].
Different new strategies have been identified for adjusting
for known biases and enhancing the cross-population
comparability [12], which would be attractive to apply to
SF-36 self-reported data in future studies.
In our study, besides looking at long-standing diseases, we
included a list of symptoms. We found that the most fre-
quently reported symptoms were shoulder, neck, back,
arm, leg problems, and headache. These symptoms are
probably mostly related to musculoskeletal problems.
When comparing musculoskeletal diseases with reported
shoulder, neck and back problems, diseases proved to be
more severe than symptoms, which was reflected in lower
SF-36 combined scores. Psychiatric disorders were ranked
relatively high with regards to severity of diseases but had
a relatively low self-reported frequency (1–1.5%). On the
other hand, melancholy/depression, the most severe
Table 4: The Influence of Sex, Age, Education and Diseases on SF-36 Combined Score by Logistic Regression Analyses.
Model 1 Model 2 Model 3
Explanatory variables Socio-demographic group Disease group Socio-economy and diseases
B S.E. Sig. B S.E. Sig. B S.E. Sig.
Constant -0.675 0.103 0.000 0.521 0.107 0.000 0.377 0.136 0.005
Sex 0.511 0.069 0.000 0.549 0.073 0.000 0.501 0.075 0.000
Age (years)
16–24 1.518 0.141 0.000 1.187 0.139 0.000 1.081 0.155 0.000
25–44 1.174 0.104 0.000 0.932 0.113 0.000 0.829 0.118 0.000
45–64 0.805 0.103 0.000 0.712 0.113 0.000 0.664 0.116 0.000
Socio-economic group
Education 0.568 0.083 0.000 0.306 0.120 0.011
Disease
Cardiovascular -1.245 0.160 0.000 -1.107 0.286 0.000
Malignant neoplasm -0.854 0.304 0.005 -2.484 1.094 0.023
Endocrine diseases -0.819 0.211 0.000 -1.016 0.442 0.022
Psychiatric disorders -2.370 0.331 0.000 -2.486 0.791 0.002
Nervous system -0.805 0.158 0.000 -0.471 0.314 0.133
Respiratory diseases -0.948 0.147 0.000 -1.842 0.358 0.000
Digestive diseases -1.051 0.218 0.000 -0.959 0.414 0.020
Genito-Urinary diseases -0.749 0.368 0.042 -0.905 0.927 0.329
Skin diseases -0.454 0.244 0.063 -0.380 0.574 0.508
Muscular-skeletal diseases -1.469 0.094 0.000 -1.817 0.201 0.000
Injuries -0.607 0.191 0.002 0.045 0.461 0.922
Other diseases -0.999 0.162 0.000 -1.832 0.450 0.000
Interaction:
ISCED * Respiratory 1.219 0.400 0.002
ISCED * Muscular-skeletal 0.485 0.230 0.035
Coding
Sex: female = 0, male = 1
Age: baseline category: 65+
ISCED: low = 0, high = 1
SF-36 comb: score 0–79 = 0, score 80–100 = 1Population Health Metrics 2006, 4:3 http://www.pophealthmetrics.com/content/4/1/3
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symptom for both sexes, had a moderately high frequency
of reporting (3–7%). It is important to be aware of these
relationships for the planning of resource allocation in
preventive, curative, and rehabilitative health services.
Since consequences here are measured on a continuous
scale, from 0 to 100 (from worst health or most conse-
quences to optimal health or fewest consequences), they
would be relatively easy to use as necessary inputs in con-
structing summary measures of population health, like
QALY, DALY, and HALE. A comparison of the self-
reported SF-36 combined raw scores from the Danish sur-
vey (not stratified by sex, age, and SES) and the hypothet-
ical expert-evaluated disability weights from 15 roughly
comparable single conditions from the Global Burden of
Disease Study [13] and from the Dutch Disability Weight
Project [14] showed high Pearson correlation coefficients
of 0.742 (p < 0.01) and 0.850 (p < 0.01) respectively.
Therefore, not only in our study the SF-36 indicates rela-
tively high average scores on all scales. Even among per-
sons reporting diseases, the average scale scores are
usually high (50+), and for self-reported completely
healthy persons we can rarely obtain over 90 in average
scale scores. This is possibly due to a problem with the SF-
36 scale's arbitrary scoring system.
We have observed large gender differences in our study
according to severities of symptoms and diseases. Females
reported more frequently and with higher severities all
symptoms and most diseases than males did. This is an
important finding because it shows that the higher self-
reported female morbidity is not caused by an over-
reporting of milder causes only. It is likely, but only spec-
ulative based on our data, that it reflects the existence of
real gender differences in health, not only a gender gap
resulting from different perceptions or willingness to
report illness. Research in gender differences in health has
pointed towards the different social roles. For example,
MacIntyre et al. [15] claim that the many societal changes
during the last decades are likely to have produced differ-
ences in male and female health status. However, this
appears to be not entirely correct considering for example
Lindhardt's [16] investigation from Denmark in the
1950s, which showed almost the same gender gap in pat-
terns of morbidity as we see today.
Socio-economic differences in the SF-36 combined scores
were apparent when both income and education were
used. The SF-36 combined score was much lower for less
educated and low-income groups than for others with
higher education and income, with the exception of the
mental health domain. The SES gradient is also found for
the same survey population in relation to self-reported
long-standing illness and perceived general health [17].
Our results show that a low educational level is associated
with higher disease prevalence compared to higher educa-
tional levels, especially for reported cardiovascular, musc-
uloskeletal and endocrine diseases, and for females,
psychiatric disorders and respiratory diseases as well.
Based on the logistic regression analysis we determined
that reported respiratory and musculoskeletal diseases
Table 5: Prevalence and Ranking of Disease Groups According to Age-adjusted SF-36 Dimensions and Combined Scores (100 = 
Optimal) on Educational Groups (ISCED). Males.
ISCED Rank Disease Prevalence % BP GH MH PF RE RP SF VI SF-36 Comb
High 1 Psychiatric disorders 1.4 74.9 56.0 68.0 87.7 54.4 63.3 72.3 56.4 66.6
2 R e s p i r a t o r y  d i s e a s e s 5 . 0 7 9 . 56 6 . 38 1 . 08 4 . 15 7 . 67 6 . 59 1 . 26 7 . 1 7 5 . 4
3 Cardiovascular diseases 5.2 80.0 64.4 79.1 86.5 71.7 71.3 86.5 66.3 75.7
4 Injuries 3.7 68.5 73.4 80.5 81.5 86.1 77.6 89.1 67.7 78.1
5 N e r v o u s  s y s t e m 4 . 4 7 7 . 67 0 . 28 0 . 18 6 . 07 8 . 77 6 . 39 0 . 06 9 . 1 7 8 . 5
6 Musculoskeletal diseases 11.8 69.6 71.1 81.7 85.7 82.4 78.8 92.0 68.0 78.7
7 S k i n  d i s e a s e s 1 . 3 6 9 . 67 1 . 18 1 . 78 5 . 78 4 . 67 8 . 89 2 . 06 8 . 0 7 8 . 9
8 D i g e s t i v e  d i s e a s e s 2 . 0 7 3 . 17 4 . 98 0 . 68 9 . 38 1 . 18 2 . 19 4 . 56 4 . 6 8 0 . 0
9 O t h e r  d i s e a s e s 3 . 5 8 0 . 06 8 . 68 3 . 98 9 . 48 1 . 58 1 . 69 2 . 46 9 . 0 8 0 . 8
1 0 E n d o c r i n e  d i s e a s e s 2 . 3 8 6 . 36 6 . 87 9 . 79 1 . 07 9 . 48 8 . 69 3 . 26 8 . 3 8 1 . 7
Low 1 Psychiatric disorders 1.4 48.2 20.6 53.2 67.5 54.4 58.0 62.4 36.6 50.1
2 R e s p i r a t o r y  d i s e a s e s 6 . 1 5 8 . 54 3 . 07 0 . 76 1 . 05 7 . 64 3 . 78 0 . 04 9 . 5 5 8 . 0
3 Endocrine diseases 4.2 55.4 47.5 79.8 59.4 79.4 29.7 83.4 56.1 61.3
4 O t h e r  d i s e a s e s 5 . 0 5 9 . 65 2 . 06 7 . 96 2 . 78 1 . 56 8 . 76 5 . 35 0 . 8 6 3 . 6
5 D i g e s t i v e  d i s e a s e s 4 . 5 5 8 . 75 3 . 78 0 . 06 2 . 98 1 . 15 3 . 08 1 . 85 8 . 8 6 6 . 3
6 S k i n  d i s e a s e s 2 . 2 6 2 . 55 0 . 38 1 . 56 5 . 98 4 . 66 1 . 98 0 . 45 6 . 2 6 7 . 9
7 Cardiovascular diseases 9.3 67.9 52.2 77.4 69.5 71.7 64.2 80.6 62.3 68.2
8 Musculoskeletal diseases 21.2 59.1 58.6 78.9 72.1 82.4 59.2 85.2 59.5 69.4
9 N e r v o u s  s y s t e m 5 . 8 7 7 . 36 7 . 27 8 . 38 1 . 87 8 . 76 8 . 68 4 . 36 8 . 0 7 5 . 5
1 0 I n j u r i e s 3 . 7 6 8 . 66 9 . 38 9 . 27 8 . 78 6 . 17 2 . 69 5 . 57 9 . 2 7 9 . 9Population Health Metrics 2006, 4:3 http://www.pophealthmetrics.com/content/4/1/3
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have interaction with education on the SF-36 combined
score. This means that the SF-36 combined score for a
given self-reported disease is dependent on the educa-
tional class to which people belong. This affects the rank-
ing of diseases, so ranking should be separate for different
educational groups. Burström and colleagues [18] utilized
the five domains of EuroQol to obtain mean health-
related quality of life weights from a survey of the Swedish
population. They found a gradient of health-related qual-
ity of life by age, sex, and SES that is consistent with our
results from Denmark using the SF-36. For most diseases
females reported more problems in each of the domains
of EuroQol, with the exception of self-care. Males with
depression and asthma reported more problems in the
EuroQol anxiety/depression domain than females did.
Interaction between SES and diseases was not found in the
study.
Interpretations of the results from studies that aim to
measure health-related quality of life in specific patient
groups are very dependent on the availability of similar
measurements from reference groups, the so-called "nor-
mal" populations. It is important to know the occurrence
of the different measures of quality of life in a normal
population, as well as factors other than illness itself, e.g.
treatment of diseases, that potentially influence the study
population's quality of life. The present study could be
used as a reference study of the Danish adult population.
Construct validity and differential item functioning in the
SF-36 from the same Danish survey have been thoroughly
analysed in other studies [3-6]. The variation by age and
sex showed that on all SF-36 dimensions males scored
higher than females (better health). For dimensions that
reflect physical health there was a tendency to lower scores
by age (worse health). For scales reflecting mental health,
there was no clear age pattern. The inventors of the SF-36
point out that the instrument is suitable for self-adminis-
tration and has been administered successfully in general
population surveys as well as to young and old adult
patients with specific diseases [19]. However, a British
study found systematic differences in health ratings for
the SF-36 by mode of administration. Postal self-com-
pleted response ratings were systematically lower than
interview-administrated ratings [20]. Some studies also
express concerns about using the questionnaire for older
people [21,22].
We could have chosen not to adjust self-reported diseases
and symptoms for age differences, since it would stand-
ardize differences in severity that obviously are influenced
by age. If we were interested in having a measure for the
actual reported consequences of the diseases and symp-
toms from a need-based care perspective, it would be
most logical to use the un-standardized scores. Older peo-
ple would naturally have the highest disease burden
because they suffer from more symptoms and diseases
Table 6: Prevalence and Ranking of Disease Groups According to Age-adjusted SF-36 Dimensions and Combined Scores (100 = 
Optimal) on Educational Groups (ISCED). Females.
ISCED Rank Disease group Prevalence % BP GH MH PF RE RP SF VI SF-36 comb
High 1 Psychiatric disorders 1.5 69.3 53.7 64.1 77.7 54.4 59.2 72.7 51.3 62.8
2 Digestive diseases 2.8 57.4 63.4 70.7 81.0 81.1 71.0 81.1 53.2 69.9
3 Cardiovascular 
diseases
3.6 67.1 59.9 75.6 79.3 71.7 63.6 84.2 58.3 70.0
4 Musculoskeletal 
diseases
14.1 57.9 64.3 75.9 76.5 82.4 64.5 85.8 59.8 70.9
5 Respiratory diseases 4.9 70.9 64.8 80.2 78.9 57.6 74.5 87.0 62.4 72.0
6 Other diseases 5.1 66.5 65.9 77.1 80.9 81.5 67.6 84.9 60.4 73.1
7 Nervous system 4.4 67.7 64.2 77.7 81.4 78.7 71.2 86.5 62.1 73.7
8 Injuries 2.4 67.6 74.9 79.6 83.2 86.1 74.5 86.6 67.0 77.5
9 Skin diseases 2.2 75.2 67.2 76.2 83.1 84.6 79.4 91.7 63.3 77.6
10 Endocrine diseases 2.2 78.4 69.8 80.4 86.5 79.4 81.0 91.2 67.6 79.3
Low 1 Respiratory diseases 7.2 59.1 43.4 72.4 58.3 57.6 35.4 84.4 47.9 57.3
2 Psychiatric disorders 3.2 52.3 54.9 61.9 70.9 54.4 48.1 74.3 54.9 58.9
3 Other diseases 4.9 54.4 51.0 66.8 55.3 81.5 47.9 76.0 48.5 60.2
4 Cardiovascular 
diseases
12.6 58.3 51.1 71.2 56.7 71.7 49.5 77.8 50.2 60.8
5 Musculoskeletal 
diseases
25.8 50.8 51.3 74.5 57.5 82.4 44.5 77.7 53.5 61.5
6 Nervous system 9.2 55.0 54.5 74.9 62.7 78.7 47.8 76.3 57.1 63.4
7 Endocrine diseases 6.4 66.8 58.0 76.5 61.5 79.4 48.1 81.8 58.8 66.4
8 Digestive diseases 6.3 58.6 56.0 77.2 64.5 81.1 55.0 81.0 60.2 66.7
9 Skin diseases 1.9 71.4 67.8 85.5 82.7 84.6 74.6 93.1 67.6 78.4
1 0 I n j u r i e s 3 . 8 6 9 . 76 9 . 08 5 . 585.9 86.1 81.0 91.0 66.3 79.3Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Population Health Metrics 2006, 4:3 http://www.pophealthmetrics.com/content/4/1/3
Page 10 of 10
(page number not for citation purposes)
with age. However, since we are interested in being able to
use results for international comparative studies of the
individual burden with focus on the severity of diseases
and symptoms regardless of individual age, we have used
indirect age standardization.
In conclusion, using a combined score aggregated on the
basis of the eight SF-36 dimensions seems to be a feasible
way to rank diseases and symptoms to assess empirical
population reporting of health status. Musculoskeletal
symptoms and diseases are the most commonly reported,
while psychiatric disorders and respiratory diseases are the
most severe diseases reported. Sex, age, and SES affect the
SF-36 score. However, certain reported diseases also inter-
act with SES (education), which prevents estimating the
severity as an unambiguous disease-specific SF-36 com-
bined score. The difference in severity according to SES
means that a single reported disease will appear more or
less severe, i.e. there will be a change in its rank ordering
depending on the SES. Our recommendation is, therefore,
that severity estimates for diseases and symptoms be inter-
preted with caution or stratified for socio-economic
groups.
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